New shot could tame severe gum disease
NCT ID NCT07603713
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called LP-005, given as an injection into the gums, for people with moderate-to-severe gum disease (periodontitis). About 100 adults aged 18-70 will receive either the drug or a placebo to see if it reduces gum inflammation, bleeding, and bone loss. The trial lasts about 6 months and also checks for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIODONTITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University School and Hospital of Stomatology
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pomegranate peel gel boost gum healing?
- A tiny camera may help dentists see below the gumline — a trial puts it to the test
- Can a thermosensitive gel help gums heal better after deep cleaning?
- Gum disease severity: could gender and lifestyle hold the key?
- Could the timing of your period change how much a dental cleaning hurts?
- Could a common disinfectant improve dental cleanings for gum disease?